These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27380738)

  • 1. Progesterone Receptor Signaling Mechanisms.
    Grimm SL; Hartig SM; Edwards DP
    J Mol Biol; 2016 Sep; 428(19):3831-49. PubMed ID: 27380738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.
    Proietti CJ; Cenciarini ME; Elizalde PV
    Steroids; 2018 May; 133():75-81. PubMed ID: 29317254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.
    Cenciarini ME; Proietti CJ
    Steroids; 2019 Dec; 152():108503. PubMed ID: 31562879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer.
    Brisken C; Scabia V
    J Mol Endocrinol; 2020 Jul; 65(1):T81-T94. PubMed ID: 32508307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
    Faivre E; Skildum A; Pierson-Mullany L; Lange CA
    Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
    Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
    Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone/RANKL is a major regulatory axis in the human breast.
    Tanos T; Sflomos G; Echeverria PC; Ayyanan A; Gutierrez M; Delaloye JF; Raffoul W; Fiche M; Dougall W; Schneider P; Yalcin-Ozuysal O; Brisken C
    Sci Transl Med; 2013 Apr; 5(182):182ra55. PubMed ID: 23616122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
    Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
    Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
    Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
    Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor transcription and non-transcription signaling mechanisms.
    Leonhardt SA; Boonyaratanakornkit V; Edwards DP
    Steroids; 2003 Nov; 68(10-13):761-70. PubMed ID: 14667966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive tissue selective actions of progesterone receptors.
    Mulac-Jericevic B; Conneely OM
    Reproduction; 2004 Aug; 128(2):139-46. PubMed ID: 15280552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms.
    Conneely OM; Mulac-Jericevic B; Lydon JP
    Steroids; 2003 Nov; 68(10-13):771-8. PubMed ID: 14667967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone involvement in breast development and tumorigenesis--as revealed by progesterone receptor "knockout" and "knockin" mouse models.
    Ismail PM; Amato P; Soyal SM; DeMayo FJ; Conneely OM; O'Malley BW; Lydon JP
    Steroids; 2003 Nov; 68(10-13):779-87. PubMed ID: 14667968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
    Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
    Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells.
    Richer JK; Jacobsen BM; Manning NG; Abel MG; Wolf DM; Horwitz KB
    J Biol Chem; 2002 Feb; 277(7):5209-18. PubMed ID: 11717311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform.
    Mulac-Jericevic B; Lydon JP; DeMayo FJ; Conneely OM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9744-9. PubMed ID: 12897242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.